![Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | BioSpace Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | BioSpace](https://mms.businesswire.com/media/20201005005212/en/826961/4/AermonyRespiClick_ENG.jpg)
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | BioSpace
1 LÄKEMEDLETS NAMN 2 KVALITATIV OCH KVANTITATIV SAMMANSÄTTNING 3 LÄKEMEDELSFORM 4 KLINISKA UPPGIFTER 4.1 Terapeutiska indikat
![AirDuo RespiClick® (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder | Low Cost AirDuo RespiClick® (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder | Low Cost](https://hcp.myairduo.com/modules/Teva.AirDuoHCP/Client/Images/low-cost-redesign.png)
AirDuo RespiClick® (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder | Low Cost
![Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development](https://drugdiscoverytrends.com/wp-content/uploads/2019/10/Inhaler.png)